Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 45785 

Drug Schedule 

Methadone intermediate (9254) ... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers for formulation 

into finished pharmaceuticals. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than October 6, 2008. 

Dated: July 29, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–17963 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on June 11, 2008, 

American Radiolabeled Chemical, Inc., 

101 Arc Drive, St. Louis, Missouri 

63146, made application by renewal to 

the Drug Enforcement Administration 

(DEA) as a bulk manufacturer of the 

basic classes of controlled substances 

listed in schedules I and II: 

Drug Schedule 

Gamma hydroxybutyric acid 

(2010).

I 

Ibogaine (7260) ............................. I 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (7370) ...... I 

Dimethyltryptamine (7435) ............ I 

1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).I 

Dihydromorphine (9145) ............... I 

Normorphine (9313) ...................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............. II 

Amobarbital (2125) ....................... II 

Phencyclidine (7471) .................... II 

Phenylacetone (8501) ................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................. II 

Drug Schedule 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ......................... II 

Metazocine (9240) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) .................... II 

Phenazocine (9715) ...................... II 

Fentanyl (9801) ............................. II 

The company plans to manufacture 

small quantities of the listed controlled 

substances as radiolabeled compounds 

for biochemical research. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than October 6, 2008. 

Dated: July 29, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–17971 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on May 23, 2008, 

Austin Pharma, LLC., 811 Paloma Drive, 

Suite A, Round Rock, Texas 78665–

2402, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Alphamethadol (9605) .................. I 

Nabilone (7379) ............................ II 

Methadone (9250) ........................ II 

Methadone Intermediate (9254) ... II 

Levo-alphacetylmethadol (9648) .. II 

Alfentanil (9737) ........................... II 

Drug Schedule 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

In reference to drug code 7360 

(Marihuana), the company plans to bulk 

manufacture cannabidiol as a synthetic 

intermediate. This controlled substance 

will be further synthesized to bulk 

manufacture a synthetic THC (7370). No 

other activity for this drug code is 

authorized for this registration. 

Any other such applicant, and any 

person who is presently, registered with 

DEA to manufacture such substances 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than October 6, 2008. 

Dated: July 30, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator/Deputy Chief 

of Operation, Office of Diversion Control, 

Drug Enforcement Administration. 

[FR Doc. E8–18046 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on June 27, 2008, 

Cody Laboratories, 601 Yellowstone 

Avenue, Cody, Wyoming 82414, made 

application by renewal to the Drug 

Enforcement Administration (DEA) as a 

bulk manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Dihydromorphine (9145) ............... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Phenylacetone (8501) .................. II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

mstockstill on PROD1PC66 with NOTICES